✦ LIBER ✦

Preliminary results of a randomized study on first and second line chemotherapy strategy in stage IV non-small cell lung cancer (NSCLC), assessing docetaxel (D) and cisplatin (C) until progressive disease (PD) then vinorelbine (V) versus V-C until PD then D

✍ Scribed by Douillard, J; Gervais, R; Lacroix, H; Le Groumellec, A; Spaeth, D; D'arlhac, M; Clary, C; Caillaud, D; Coudert, B; Maury, B; Monnier, A; Mornet, M; Zalcman, G; Foucher, P; Duhamel, J.P; Schuller-Lebeau, M.P

Book ID: 118569845
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 227 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80300-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-554 Randomized Phase II study of first

P-554 Randomized Phase II study of first-line docetaxel (D)/ gemcitabine (G) doublet chemotherapy versus fixed duration (3 cycles) sequential single agent chemotherapy (D then G) in Stage IIIB/IV non-small cell lung cancer (NSCLC)—Final Results. A study by the NSW and Australian Lung Cancer Trials Group

✍ Pavlakis, N.; McCowatt, S.; Lewis, C.; Marx, G.; Abell, F.; Della-Fiorentina, S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB